NIPT Outperforms Standard Screening for T21 but False Positives Call for Caution, NEJM Studies Find

Cell-free DNA Analysis for Noninvasive Examination of Trisomy NEJM Original article

Accurate Description of DNA-Based Noninvasive Prenatal Screening NEJM Correspondence

Use of Cell-free DNA to Screen for Down’s Syndrome NEJM Editorial

Copy-Number Variation and False Positive Prenatal Aneuploidy Screening Results NEJM Brief Report

GenomeWeb – Noninvasive prenatal testing (NIPT) for trisomies and other chromosomal aneuplodies using cell-free DNA from the mother’s blood has been spreading quickly in maternal-fetal medicine in recent years and is poised to move from high-risk to average-risk pregnancy populations.

Three new studies, published online in the New England Journal of Medicine today, shed light on how these tests may be best integrated into clinical care for all pregnant women.

Read more


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s